2022 a year in Review

Dear Immunify.Life Community,

Despite a very challenging environment, 2022 was a year of significant achievement for Immunify.Life.

We built our Community, secured partnerships and evolved our technology to the point where we are now improving and saving lives of HIV/AIDS patients in Africa aspart of our ongoing clinical collaboration with Masinde Muliro University ofScience & Technolo. Additionally, we commenced our public sale.

What is clear to me, as Founder, is that in 2022 Immunify.Life has  started to deliver on its compelling promise& vision to use blockchain technology to improve the health and well-being of those in need across the world and specifically in Africa.

At the end of 2022 we are now closer to fulfilling our mission to transform the landscape of health management and data utilisation as we know it, and to help strengthen healthcare systems where ever we operate.

Listed below are a few of our milestone achievements for 2022. I have included links to various announcements and media coverage.

WorldMobile partnership   

This significant partnership included the deployment of Immunify’s DApp to the WorldMobile ecosystem, greatly expanding the audience for their healthcare App while offering additional utility to World Mobile users

https://worldmobile.io/blog/post/immunify-partnership/

Closing $2M Strategic funding round

Successful closing of the initial funding round for which the funds raised will be used to implement in-country fieldwork to address global challenges including HIV treatment rates, and vaccination programmes in Africa.

https://www.bloomberg.com/press-releases/2022-09-16/immunify-life-successfully-closes-initial-fundraising-rounds-securing-2m-from-blue-chip-blockchain-vcs

Commencement of world first HIV Study in Kenya

In August Immunify.Life and Masinde Muliro University of Science & technology commenced a clinical study in Kenya investigating the effectiveness of crypto based incentives and paperless tracking systems in HIV/AIDS treatment adherence outcomes in low socio-economic settings. This ground breaking study involving 600 patients will contribute to the future policy direction of HIV treatment in Kenya

https://www.globenewswire.com/en/news-release/2022/09/26/2522827/0/en/Immunify-Life-Launches-Groundbreaking-Blockchain-Based-HIV-AIDS-Treatment-Outcomes-Study.html

In earlyDecember the study reached a significant milestone with the successful screening of over 100 HIV/AIDS patients. These are people who has dropped of treatment and were heading towards a premature death

https://www.immunify.life/news/immunify-life-screens-100-patients-in-ground-breaking-hiv-study-in-kenya

Ethics and Regulatory approval of Zambia COVID vaccination Study

Ethical and Regulatory clearance to commence our COVID study was granted by the MedicalEthics & Research Committee from the University of Zambia. The study to be conducted in three significant government run clinics.

Presenting at Cardano Summit in Edinburgh

Immunify.Life was invited to participate in the panel discussion “Building on Cardano inAfrica” in Edinburgh with John O’Connor, and World Mobile and Empower and featured in Cardano 360.

https://www.youtube.com/watch?v=TGEeTxv7Z-o

Meeting with Zambian Minister of Health regarding Malaria treatment programme

We had a productive meeting with the Minister of Health and her executive team which was held in early December 2022. Immunify.Life has contributed to the first steps in developing a module to help fight Malaria.

Opening of Immunify Treasury (public token sale)

Despite strong market headwinds we took the decision to commence our public sale on purpose-developed platform that allows users to safely and securely reserve allocation and purchase IMM tokens. www.immunify.life

https://immunify-life.medium.com/the-immunify-life-public-sale-a-step-by-step-guide-of-the-treasury-f277bd43ca9a

2023 - The Road Ahead.

We have now laid the platform for a dynamic and successful 2023. Highlights of our plan include our Token listing and staking pools, commencement of vaccination and Malaria project in Zambia, and the data collection projects that will drive real organic token demand and revenue.

Whilst reflecting on what we achieved this year and on our future plans, it is clear to me and the entire Immunify Management team that these milestones could not have been achieved without the support of our Community and we wish to thank you for your unwavering support.

‍

Guy Newing

Founder, Immunify.Life

‍